Add a listing
    Add a listing

    BlueRock Therapeutics

      Genetically engineered iPSC-derived cells.

    General
    • Headquarters

      New York 10016, United States

    • Founders & Team

      Gordon Keller

    • Year Founded

      2016

    • Number of employees

      200

    • Company type

      Private company

    • Total funding ($M)

      225

    Technical Details
    • Aging Target

      Cell Loss

    • Disease indication

      Parkinson's

    • Product modality

      cell therapy, gene therapy, stem cells

    About

    BlueRock Therapeutics is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock Therapeutics’ cell+gene platform harnesses the power of cells to create new medicines for neurology, cardiology, and immunology indications.

    How much is an extra decade of life worth to you? Make a bet on longevity science today.

    Donate to Impetus Grants

    You May Also Be Interested In